Ceng Xiaofeng

[Expert Profile] Zeng Xiaofeng, Chief Physician, Professor, Doctoral Supervisor, is a leading figure in rheumatology and immunology in China, working in the Department of Rheumatology, Peking Union Medical College Hospital. He has long been dedicated to the clinical diagnosis, treatment, and scientific research of difficult rheumatic and autoimmune diseases such as systemic lupus erythematosus, Sjogren's syndrome, systemic vasculitis, and Behcet's disease, and is an important promoter of rheumatology discipline development in China.

[Education & Career] Professor Zeng Xiaofeng graduated from Peking Union Medical College, completing systematic clinical training in the Department of Rheumatology at Peking Union Medical College Hospital. As the birthplace of rheumatology in China, the international perspective and rigorous academic style of PUMCH's rheumatology department deeply influenced his academic career. He has long held important academic positions including Chair of the Rheumatology Branch of the Chinese Medical Association and President of the Rheumatology Physicians Branch of the Chinese Medical Doctor Association. He has presided over major projects including key grants from the National Natural Science Foundation of China and the "13th Five-Year Plan" National Key R&D Program, and is a representative leader in the field of rheumatology in China.

[Areas of Expertise] Professor Zeng is proficient in the diagnosis and treatment of various rheumatic and autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, systemic vasculitis, Behcet's disease, and rheumatoid arthritis. He has extensive experience particularly in difficult and severe lupus (lupus nephritis, lupus encephalopathy), refractory vasculitis, and complex cases involving multiple autoimmune diseases. He emphasizes "precise diagnosis, stratified treatment, and whole-course management," excelling at developing individualized immunotherapy regimens based on disease activity and organ involvement, helping numerous patients control their conditions, reduce relapse, and protect organ function.

[Academic Achievements & Industry Contributions] Professor Zeng has led the establishment of a nationwide large-scale rheumatic disease clinical registry and research network, systematically mapping out real-world characteristics and current diagnosis/treatment status of conditions such as systemic lupus erythematosus in China. His research findings have been published in top international rheumatology journals, providing important evidence for the development of Chinese rheumatology prevention and treatment policies. He has led the development and updating of multiple Chinese rheumatic disease diagnosis and treatment guidelines and expert consensus statements, actively promoted the standardized construction of rheumatology departments nationwide and specialist physician training, significantly improving the overall diagnosis and treatment level and international influence of Chinese rheumatology.

[Clinical Practice & Outstanding Contributions] Professor Zeng has long held expert rheumatology clinics at PUMCH, with annual outpatient volume ranking among the highest nationwide, cumulatively treating tens of thousands of patients with various rheumatic diseases, including many difficult and severe cases who traveled from across the country. Leading his team, he has enabled countless systemic lupus erythematosus patients to achieve long-term remission and return to normal life, and has identified diagnoses and saved lives for numerous patients with difficult vasculitis. He has received multiple national and industry honors, and is a truly deserving discipline leader in Chinese rheumatology. His physician's dedication of "not giving up on any patient" is deeply loved by patients.

[Honors & Reputation] Professor Zeng Xiaofeng holds multiple academic positions including Chair of the Rheumatology Branch of the Chinese Medical Association and President of the Rheumatology Physicians Branch of the Chinese Medical Doctor Association. He has presided over national-level projects including the National Key R&D Program and key grants from the National Natural Science Foundation of China, and is an authoritative expert in the field of rheumatology and immunology in China. He led the establishment of the Chinese Systemic Lupus Erythematosus Research Collaboration Group (CSTAR), systematically conducting large-scale real-world studies on rheumatic diseases including lupus, Sjogren's syndrome, vasculitis, and Behcet's disease, bringing Chinese rheumatic disease clinical research to the international forefront. His research findings have been published in top international journals and received multiple science and technology awards. He has actively promoted standardized rheumatic disease diagnosis and department construction, trained a large number of rheumatology professionals, and is deeply trusted by patients and respected by peers alike.